Total Funding
78
72
Total FundingPost-IPO Equity raised
Growth Score
-15 pts
Heat Score
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
6911
Zura Bio is a clinical-stage, multi-asset biotechnology company.
- Verender Badial: Chief Financial Officer
- Tauhid Ali: COO & DirectorPast Role: Takeda, Vice President TAKcelerator
About the Company
Zura Bio is a clinical-stage, multi-asset biotechnology company dedicated to developing novel dual-pathway antibody medicines for the treatment of serious autoimmune and inflammatory disorders. The company’s approach—targeting two disease-driving mechanisms at once—is designed to offer potentially greater efficacy, safety, and dosing advantages
over single-target treatments.
